BofA initiates Immix Biopharma stock with buy rating on AL amyloidosis drug
BofA initiates Immix Biopharma stock with buy rating on AL amyloidosis drug
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.